blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0744952

EP0744952 - METHOD FOR TREATING VASCULAR OBSTRUCTIONS CAUSED BY ABNORMAL CELLS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.09.1997
Database last updated on 19.10.2024
Most recent event   Tooltip05.09.1997Application deemed to be withdrawnpublished on 22.10.1997 [1997/43]
Applicant(s)For all designated states
Emory University
1364 Clifton Road, N.E., Box M-11
Atlanta, GA 30322 / US
[N/P]
Former [1996/49]For all designated states
EMORY UNIVERSITY
1380 South Oxford Road
Atlanta, GA 30322 / US
Inventor(s)01 / HUNTER, Robert L.
3640 Churchwell Court
Tucker, Georgia 30084 / US
[1996/49]
Representative(s)Sternagel, Hans-Günther, et al
Patentanwälte Sternagel & Fleischer Braunsberger Feld 29
51429 Bergisch Gladbach / DE
[N/P]
Former [1996/49]Sternagel, Hans-Günther, Dr., et al
Patentanwälte Dr. Michael Hann Dr. H.-G. Sternagel, Sander Aue 30
51465 Bergisch Gladbach / DE
Application number, filing date92918261.614.08.1992
[1996/49]
WO1992US06867
Priority number, dateUS1991074506614.08.1991         Original published format: US 745066
[1996/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9303738
Date:04.03.1993
Language:EN
[1993/06]
Type: A1 Application with search report 
No.:EP0744952
Date:04.12.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.1993 takes the place of the publication of the European patent application.
[1996/49]
Search report(s)International search report - published on:US04.03.1993
ClassificationIPC:A61K31/765
[1996/49]
CPC:
A61K31/77 (EP,US); A61K31/765 (EP,US); A61K38/166 (EP,US);
A61K38/446 (EP,US); A61K38/49 (EP,US); A61P33/02 (EP);
A61P7/02 (EP); A61P9/00 (EP); Y02A50/30 (EP) (-)
C-Set:
A61K38/446, A61K2300/00 (EP,US);
A61K38/49, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   SE [1996/49]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON GEFÄSSOBSTRUKTIONEN VERURSACHT DURCH ABNORMALE ZELLEN[1996/49]
English:METHOD FOR TREATING VASCULAR OBSTRUCTIONS CAUSED BY ABNORMAL CELLS[1996/49]
French:PROCEDE DE TRAITEMENT DES OBSTRUCTIONS VASCULAIRES PROVOQUEES PAR DES CELLULES ANORMALES[1996/49]
File destroyed:13.09.2003
Entry into regional phase16.02.1994National basic fee paid 
16.02.1994Search fee paid 
16.02.1994Designation fee(s) paid 
16.02.1994Examination fee paid 
Examination procedure02.03.1993Request for preliminary examination filed
International Preliminary Examining Authority: DE
16.02.1994Examination requested  [1996/49]
06.03.1995Application deemed to be withdrawn, date of legal effect  [1997/43]
28.05.1997Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1997/43]
Fees paidRenewal fee
16.08.1994Renewal fee patent year 03
17.08.1995Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.08.199605   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US3590125  (HYMES ALAN C);
 [A]US3450502  (HYMES ALAN C);
 [A]US3641240  (HYMES ALAN C, et al);
 [A]US4186253  (IWAI MASAKAZU [JP], et al);
 [A]US4609546  (HIRATANI HAJIME [JP])
 [A]  - AMERICAN JOURNAL OF HEMATOLOGY, Volume 19, issued 1985, C.A. RIENDORF et al., "Perfluorocarbon Compounds: Effects on the Rheological Properties of Sickle Erythrocytes In Vitro", pages 229-236.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.